Page
%P
-
Article
Open AccessAuthor Correction: Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
-
Article
Open AccessCantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA
Cantharidin is an active constituent of mylabris, a traditional Chinese medicine and is a potent and selective inhibitor of protein phosphatase 2A (PP2A) that plays an important role in cell cycle control, apo...
-
Article
Open AccessDevelopment of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Current therapies are insufficient, making HCC an intractable disease. Our previous studies confirmed that inhibi...